<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Februar 2023]]></title><description><![CDATA[<p dir="auto">Sanofi Q4 Profit Climbs; Sees Higher Earnings In FY23 - Quick Facts <a href="https://www.proinvestor.com/investornyt/935822/sanofi-q4-profit-climbs-sees-higher-earnings-in-fy23-quick-facts" rel="nofollow ugc">https://www.proinvestor.com/investornyt/935822/sanofi-q4-profit-climbs-sees-higher-earnings-in-fy23-quick-facts</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400871/pharma-februar-2023</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 04:31:40 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400871.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 03 Feb 2023 06:24:46 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 28 Feb 2023 20:48:19 GMT]]></title><description><![CDATA[<p dir="auto">Den umiddelbare konsekvens er usikkerhed. Så Pfizer kan komme endnu mere på udsalg.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037686</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037686</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 28 Feb 2023 20:48:19 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 28 Feb 2023 20:46:44 GMT]]></title><description><![CDATA[<p dir="auto">Jeg tror, de køber. Seagen er primært ejet af institutionelle investeror. Sidste år prøvede de at sælge for 40 mia usd til Merck, men mislykkedes. Så de vil gerne sælge. Pfizer vil gerne købe. Og Pfizer har pengene.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037689</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037689</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 28 Feb 2023 20:46:44 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 28 Feb 2023 20:43:39 GMT]]></title><description><![CDATA[<p dir="auto">Køber Pfizer Seagen? Og hvad er konsekvensen?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037687</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037687</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 28 Feb 2023 20:43:39 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 28 Feb 2023 08:37:28 GMT]]></title><description><![CDATA[<p dir="auto">Roche Collaborates With CDC To Strengthen Laboratory Capabilities In Countries Affected By HIV &amp; TB <a href="https://www.proinvestor.com/investornyt/947540/roche-collaborates-with-cdc-to-strengthen-laboratory-capabilities-in-countries-affected-by-hiv-amp-tb" rel="nofollow ugc">https://www.proinvestor.com/investornyt/947540/roche-collaborates-with-cdc-to-strengthen-laboratory-capabilities-in-countries-affected-by-hiv-amp-tb</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037688</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037688</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 28 Feb 2023 08:37:28 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 28 Feb 2023 07:12:48 GMT]]></title><description><![CDATA[<p dir="auto">This Pharmaceuticals Company Looks To Be A Better Pick Over Procter &amp; Gamble Stock<br />
<a href="https://www.proinvestor.com/investornyt/947551/this-pharmaceuticals-company-looks-to-be-a-better-pick-over-procter-amp-gamble-stock" rel="nofollow ugc">https://www.proinvestor.com/investornyt/947551/this-pharmaceuticals-company-looks-to-be-a-better-pick-over-procter-amp-gamble-stock</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037690</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037690</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 28 Feb 2023 07:12:48 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Sun, 26 Feb 2023 13:00:15 GMT]]></title><description><![CDATA[<p dir="auto">This Big Pharma Stock Is a Clear Buy <a href="https://www.proinvestor.com/investornyt/946856/this-big-pharma-stock-is-a-clear-buy" rel="nofollow ugc">https://www.proinvestor.com/investornyt/946856/this-big-pharma-stock-is-a-clear-buy</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037683</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037683</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sun, 26 Feb 2023 13:00:15 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Thu, 23 Feb 2023 12:08:24 GMT]]></title><description><![CDATA[<p dir="auto">Moderna skuffer på indtjeningen trods stigende salg - aktien falder <a href="https://www.proinvestor.com/investornyt/945540/moderna-skuffer-pa-indtjeningen-trods-stigende-salg-aktien-falder" rel="nofollow ugc">https://www.proinvestor.com/investornyt/945540/moderna-skuffer-pa-indtjeningen-trods-stigende-salg-aktien-falder</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037681</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037681</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 23 Feb 2023 12:08:24 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Sat, 18 Feb 2023 04:44:41 GMT]]></title><description><![CDATA[<p dir="auto">Teva's AUSTEDO XR Receives FDA<br />
Approval For Movement Disorders Treatment <a href="https://www.proinvestor.com/investornyt/943498/tevas-austedo-xr-receives-fda-approval-for-movement-disorders-treatment" rel="nofollow ugc">https://www.proinvestor.com/investornyt/943498/tevas-austedo-xr-receives-fda-approval-for-movement-disorders-treatment</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037691</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037691</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 18 Feb 2023 04:44:41 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Fri, 17 Feb 2023 05:52:55 GMT]]></title><description><![CDATA[<p dir="auto">Britisk storbank løfter kursmål for Lundbeck og gentager<br />
"outperform"<a href="https://www.proinvestor.com/investornyt/943022/britisk-storbank-lofter-kursmal-for-lundbeck-og-gentager-outperform" rel="nofollow ugc">https://www.proinvestor.com/investornyt/943022/britisk-storbank-lofter-kursmal-for-lundbeck-og-gentager-outperform</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037685</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037685</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 17 Feb 2023 05:52:55 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Fri, 17 Feb 2023 05:43:00 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037679</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037679</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 17 Feb 2023 05:43:00 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Mon, 13 Feb 2023 08:25:52 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck/Sydbank: Toppen af prognosen er inden for rækkevidde <a href="https://www.proinvestor.com/investornyt/940501/lundbeck-sydbank-toppen-af-prognosen-er-inden-for-raekkevidde" rel="nofollow ugc">https://www.proinvestor.com/investornyt/940501/lundbeck-sydbank-toppen-af-prognosen-er-inden-for-raekkevidde</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037678</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037678</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 13 Feb 2023 08:25:52 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Thu, 09 Feb 2023 14:56:12 GMT]]></title><description><![CDATA[<p dir="auto">Pharma og biotek - opdatering fra debat og chat uge 6 Ambu ' Lundbeck ' ALK-Abelló ' ChemoMetec</p>
<p dir="auto">Helge Larsen kommenterer de seneste regnskaber fra virksomheder inden for pharma og biotek ud fra den kvalificerede debat og chat på <a href="http://proinvestor.com" rel="nofollow ugc">proinvestor.com</a> Kort video <a href="https://www.proinvestor.com/boards/110334" rel="nofollow ugc">https://www.proinvestor.com/boards/110334</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037680</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037680</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 09 Feb 2023 14:56:12 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Thu, 09 Feb 2023 12:15:11 GMT]]></title><description><![CDATA[<p dir="auto">NuVasive Inc. kunne være et godt bud i dag...de er lige blevet opkøbt af et konkurrerende firma...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037684</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037684</guid><dc:creator><![CDATA[MrWeeny]]></dc:creator><pubDate>Thu, 09 Feb 2023 12:15:11 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Wed, 08 Feb 2023 10:09:31 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck-topchef bruger langsigtet mål til at understrege tro på vækst <a href="https://www.proinvestor.com/investornyt/938048/lundbeck-topchef-bruger-langsigtet-mal-til-at-understrege-tro-pa-vaekst" rel="nofollow ugc">https://www.proinvestor.com/investornyt/938048/lundbeck-topchef-bruger-langsigtet-mal-til-at-understrege-tro-pa-vaekst</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037674</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037674</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 08 Feb 2023 10:09:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 14:04:50 GMT]]></title><description><![CDATA[<p dir="auto">Lundbecks kurshop skyldes til dels<br />
annullering af shorts <a href="https://www.proinvestor.com/investornyt/937507/lundbecks-kurshop-skyldes-til-dels-annullering-af-shorts" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937507/lundbecks-kurshop-skyldes-til-dels-annullering-af-shorts</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037677</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037677</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Feb 2023 14:04:50 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 12:01:33 GMT]]></title><description><![CDATA[<p dir="auto">Why Amgen is a Top 25 Dividend Giant (AMGN) <a href="https://www.proinvestor.com/investornyt/937444/why-amgen-is-a-top-25-dividend-giant-amgn" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937444/why-amgen-is-a-top-25-dividend-giant-amgn</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037673</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037673</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Feb 2023 12:01:33 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 11:41:10 GMT]]></title><description><![CDATA[<p dir="auto">Lundbecks indtjening slår forventningerne i markedet <a href="https://www.proinvestor.com/investornyt/937443/lundbecks-indtjening-slar-forventningerne-i-markedet" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937443/lundbecks-indtjening-slar-forventningerne-i-markedet</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037682</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037682</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Feb 2023 11:41:10 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 11:25:45 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck - skal den videre op?<br />
....</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037672</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037672</guid><dc:creator><![CDATA[Cupcake]]></dc:creator><pubDate>Tue, 07 Feb 2023 11:25:45 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 11:25:24 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck nedskriver på Vyepti-lagre og giver 2023-prognose <a href="https://www.proinvestor.com/investornyt/937422/lundbeck-nedskriver-pa-vyepti-lagre-og-giver-2023-prognose" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937422/lundbeck-nedskriver-pa-vyepti-lagre-og-giver-2023-prognose</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037669</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037669</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Feb 2023 11:25:24 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 07:36:31 GMT]]></title><description><![CDATA[<p dir="auto">ALK-Abelló får hævet kursmålet til 130 kr. fra 120 kr. hos Danske Bank <a href="https://www.proinvestor.com/investornyt/937349/alk-abello-far-haevet-kursmalet-til-130-kr-fra-120-kr-hos-danske-bank" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937349/alk-abello-far-haevet-kursmalet-til-130-kr-fra-120-kr-hos-danske-bank</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037670</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037670</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 07 Feb 2023 07:36:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 07:07:50 GMT]]></title><description><![CDATA[<p dir="auto">Roche Announces Positive Results From Phase III Study Of Crovalimab In PNH <a href="https://www.proinvestor.com/investornyt/937336/roche-announces-positive-results-from-phase-iii-study-of-crovalimab-in-pnh" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937336/roche-announces-positive-results-from-phase-iii-study-of-crovalimab-in-pnh</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037667</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037667</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Tue, 07 Feb 2023 07:07:50 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 07:06:29 GMT]]></title><description><![CDATA[<p dir="auto">AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure <a href="https://www.proinvestor.com/investornyt/937342/astrazeneca-european-commission-approves-forxiga-in-treatment-of-symptomatic-chronic-heart-failure" rel="nofollow ugc">https://www.proinvestor.com/investornyt/937342/astrazeneca-european-commission-approves-forxiga-in-treatment-of-symptomatic-chronic-heart-failure</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037676</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037676</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Tue, 07 Feb 2023 07:06:29 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Tue, 07 Feb 2023 05:30:01 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037671</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037671</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 07 Feb 2023 05:30:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Februar 2023 on Mon, 06 Feb 2023 13:17:57 GMT]]></title><description><![CDATA[<p dir="auto">Could This Indication Provide a Lift for Bristol Myers Squibb's Stock? <a href="https://www.proinvestor.com/investornyt/936866/could-this-indication-provide-a-lift-for-bristol-myers-squibbs-stock" rel="nofollow ugc">https://www.proinvestor.com/investornyt/936866/could-this-indication-provide-a-lift-for-bristol-myers-squibbs-stock</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037668</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037668</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 06 Feb 2023 13:17:57 GMT</pubDate></item></channel></rss>